Cogent Biosciences, Inc. (COGT)

NASDAQ: COGT · IEX Real-Time Price · USD
14.13
+0.68 (5.06%)
At close: Aug 12, 2022 4:00 PM
14.53
+0.40 (2.83%)
After-hours: Aug 12, 2022 7:54 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015
Revenue
07.8722.59.738.366.362.99
Revenue Growth (YoY)
--65.02%131.14%16.43%31.55%112.83%-
Gross Profit
07.8722.59.738.366.362.99
Selling, General & Admin
19.6417.4210.977.454.683.432.73
Research & Development
55.9125.7443.7138.2929.8321.996.85
Other Operating Expenses
046.9100000
Operating Expenses
75.5590.0754.6845.7434.5125.439.58
Operating Income
-75.55-82.2-32.18-36.01-26.15-19.07-6.59
Other Expense / Income
-3.28-7.39-0.35-1.47-0.66-0.950
Pretax Income
-72.27-74.81-31.83-34.53-25.49-18.12-6.59
Net Income
-72.27-74.81-31.83-34.53-25.49-18.12-6.59
Preferred Dividends
0104.400.020.070.060.04
Net Income Common
-72.27-179.21-31.83-34.55-25.56-18.19-6.64
Shares Outstanding (Basic)
391186333
Shares Outstanding (Diluted)
391186333
Shares Change
249.52%45.42%22.43%144.27%0.02%--
EPS (Basic)
-1.87-16.17-4.18-5.56-10.04-7.12-2.60
EPS (Diluted)
-1.87-16.17-4.18-5.56-10.04-7.12-2.60
Free Cash Flow Per Share
-1.56-3.21-5.43-5.31-10.50-8.626.17
Gross Margin
-100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
--1044.30%-143.00%-369.90%-312.80%-300.10%-220.80%
Profit Margin
--2276.80%-141.50%-354.90%-305.70%-286.20%-222.20%
Free Cash Flow Margin
--451.40%-183.80%-339.40%-319.90%-345.40%526.50%
EBITDA
-72.13-74.09-30.54-33.21-24.32-17.29-6.41
EBITDA Margin
--941.30%-135.70%-341.20%-290.90%-272.10%-214.80%
Depreciation & Amortization
0.150.721.291.321.170.830.18
EBIT
-72.27-74.81-31.83-34.53-25.49-18.12-6.59
EBIT Margin
--950.40%-141.50%-354.80%-304.90%-285.20%-220.80%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).